Companies
/
Reify Health
Healthtech
Reify Health is a Boston-based clinical trial technology company (rebranded as ClinChoice Digital following acquisition) whose software helps pharmaceutical companies and research sites recruit patients and manage clinical trial enrollment more efficiently.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Reify Health was founded in 2014 by Mark Hanson and Dan Doheny, based on the observation that clinical trial enrollment, the process of recruiting and screening patients to participate in the studies pharmaceutical companies conduct to test new drugs and treatments, has historically been one of the slowest and most unpredictable parts of the overall drug development process, with many clinical trials experiencing significant delays reaching their target enrollment numbers, delays that directly extend how long it takes for a potentially beneficial new treatment to reach approval and patients, given that clinical trial timelines are often gated primarily by how quickly a study can enroll enough qualifying patients across its various research sites. Reify Health's flagship product, StudyTeam, provides software used by clinical trial research sites, the hospitals, medical practices, and dedicated research centers that actually enroll and manage patients participating in a given clinical trial, to more efficiently track patient recruitment pipelines, manage the various screening and eligibility steps required before a patient can formally enroll in a trial, and communicate enrollment status and projections back to the pharmaceutical companies sponsoring the trial, replacing more manual, often spreadsheet-based tracking methods that made it difficult for trial sponsors to get real-time, accurate visibility into enrollment progress across the many different research sites participating in a typical multi-site clinical trial. The company's technology has aimed to address the chronic unpredictability of clinical trial enrollment timelines by giving both research sites and pharmaceutical sponsors better real-time data and predictive tools for understanding and managing the recruitment process, potentially helping identify and address enrollment bottlenecks earlier than traditional, less real-time tracking methods would surface them. Reify Health's customers span pharmaceutical and biotechnology companies conducting clinical trials, as well as the research sites and site networks that participate in running those trials. The company raised very substantial venture funding from investors including Sequoia Capital, Battery Ventures, and Adams Street Partners, reaching a valuation exceeding $8 billion during a period of intense investor interest in clinical trial technology, before being acquired and later rebranded under new ownership as part of a broader clinical research services organization.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
